Format

Send to

Choose Destination
Neurotoxicology. 2018 Jan;64:278-283. doi: 10.1016/j.neuro.2017.07.030. Epub 2017 Aug 5.

Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14.

Author information

1
Division of Pharmacology & Toxicology, College of Pharmacy, Institute for Cellular & Molecular Biology, Institute for Neuroscience, The University of Texas at Austin, 3.510E BME, 107 W. Dean Keeton, Austin, TX 78712, USA. Electronic address: som@austin.utexas.edu.

Abstract

Over the last few years, two rare, familial diseases that lead to the onset of manganese (Mn)-induced neurotoxicity have been discovered. Loss-of-function mutations in SLC30A10, a Mn efflux transporter, or SLC39A14, a Mn influx transporter, increase Mn levels in blood and brain, and induce severe neurotoxicity. The discoveries of these genetic diseases have transformed our understanding of Mn homeostasis, detoxification, and neurotoxicity. Current knowledge about the mechanisms by which mutations in these transporters alter Mn homeostasis to induce human disease is reviewed here.

KEYWORDS:

Manganese neurotoxicity; Metal homeostasis; Parkinsonism; SLC30A10; SLC39A14; ZIP14; ZnT10

PMID:
28789954
PMCID:
PMC5799044
DOI:
10.1016/j.neuro.2017.07.030
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center